secwatch / observer
8-K filed November 6, 2023, 6:59 PM ET ticker NEPH CIK 0001196298
leadership confidence high sentiment positive materiality 0.55

Nephros appoints Judy Krandel as CFO; Andrew Astor resigns effective Nov 1, 2023

NEPHROS INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Judy Krandel

Chief Financial Officer
NEPH · NEPHROS INC
Effective
2023-11-01
Filed
November 6, 2023, 6:59 PM ET
Nephros, Inc. (the “Company”) appointed Judy Krandel as its Chief Financial Officer, effective November 1, 2023.
Departed

Andrew Astor

Chief Financial Officer
NEPH · NEPHROS INC
Effective
2023-11-01
Successor
Judy Krandel
Filed
November 6, 2023, 6:59 PM ET
On November 1, 2023, in connection with Ms. Krandel’s appointment as Chief Financial Officer, Andrew Astor resigned as the Company’s Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Judy Krandel was appointed as Chief Financial Officer at NEPHROS INC.

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
Nephros, Inc. (the “Company”) appointed Judy Krandel as its Chief Financial Officer, effective November 1, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Astor resigned as Chief Financial Officer at NEPHROS INC.

Action
resigned
Role
Chief Financial Officer
Exact text from the filing
On November 1, 2023, in connection with Ms. Krandel’s appointment as Chief Financial Officer, Andrew Astor resigned as the Company’s Chief Financial Officer.
View on SEC.gov

NEPHROS INC filing history →

Source: SEC EDGAR
accession 0001493152-23-039516
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.